Hibernoma - Intense uptake seen on Tc-99m tetrofosmin and FDG positron emission tomographic scanning

被引:29
作者
Chatterton, BE
Mensforth, D
Coventry, BJ
Cohen, P
机构
[1] Royal Adelaide Hosp, Dept Nucl Med, Adelaide, SA 5000, Australia
[2] Adelaide Nucl Med, Adelaide, SA, Australia
[3] Univ Adelaide, Dept Surg, Adelaide, SA 5005, Australia
[4] Inst Med & Vet Sci, Adelaide, SA 5000, Australia
关键词
fluorodeoxyglucose; hibernoma; positron emission tomography; tetrofosmin;
D O I
10.1097/00003072-200205000-00016
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 65-year-old man with several subcutaneous masses (clinically diagnosed as lipomata), underwent Tc-99m tetrofosmin scanning for chest pain. One of these masses (in the right thigh) was incidentally noted to take up tetrofosmin. Computed tomography (CT) and magnetic resonance imaging (MRI) demonstrated a fat-containing lesion, and F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET or C-PET) showed active uptake. Biopsy showed the lesion to be a hibernoma. Hibernoma is a benign but metabolically active tumor of brown fat origin. Brown fat is a major heat producer in the newborn and contains high levels of mitochondria. This high metabolic rate probably explains the uptake of Tc-99m tetrofosmin and F-18 FDG. Nevertheless, without a biopsy, the imaging studies could not exclude liposarcoma.
引用
收藏
页码:369 / 370
页数:2
相关论文
共 7 条
[1]  
Kosuda S, 1997, Ann Nucl Med, V11, P263
[2]   Hibernoma of the medial thigh - Case report and literature review [J].
Lewandowski, PJ ;
Weiner, SD .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1996, (330) :198-201
[3]   MR and CT findings in a case of hibernoma of the thigh extending into the pelvis [J].
Mugel, T ;
Ghossain, MA ;
Guinet, C ;
Buy, JN ;
Bethoux, JP ;
Texier, O ;
Vadrot, D .
EUROPEAN RADIOLOGY, 1998, 8 (03) :476-478
[4]   Scapular hibernoma fortuitously discovered on myocardial perfusion imaging through Tc-99m tetrofosmin [J].
Oller, JD ;
Gómez, JDT ;
Kortazar, JF ;
García, JDB ;
Navarro, AA ;
Albertino, RJV ;
Díaz, JJA ;
Llorente, JAA ;
Andreu, MN ;
Arcas, RF ;
Medina, T ;
Vázquez, RJM .
CLINICAL NUCLEAR MEDICINE, 2001, 26 (01) :69-70
[5]   Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? [J].
Schulte, M ;
Brecht-Krauss, D ;
Heymer, B ;
Guhlmann, A ;
Hartwig, E ;
Sarkar, MR ;
Diederichs, CG ;
Schultheiss, M ;
Kotzerke, J ;
Reske, SN .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (06) :599-605
[6]   Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas [J].
Schwarzbach, MHM ;
Dimitrakopoulou-Strauss, A ;
Willeke, F ;
Hinz, U ;
Strauss, LG ;
Zhang, YM ;
Mechtersheimer, G ;
Attigah, N ;
Lehnert, T ;
Herfarth, C .
ANNALS OF SURGERY, 2000, 231 (03) :380-386
[7]  
Weiss S., 1995, SOFT TISSUE TUMORS, Vthird, P381